ArticleThe Lancet regional health. Western Pacific2026
Change in the life expectancy gap among people with mental illness: a 14-year population-based cohort study in Australia.
Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: People with psychiatric disorders die substantially earlier than the general population, with life expectancy gaps of 10-20 years reported internationally. Prior Australian data indicated this gap was widening, whereas evidence from other countries has been mixed. We aimed to determine whether the life expectancy gap in people with hospitalised psychiatric disorders versus the general population is changing in Queensland, Australia, and to identify which causes of death drive excess mortality. Methods: We conducted a retrospective population-based cohort study using linked Queensland hospital admissions and death registry data. Adults (≥18 years) with a principal psychiatric diagnosis across seven diagnostic categories were included, excluding dementia. Life expectancy was estimated using life-table methods and compared to Queensland norms. We calculated standardised mortality ratios (SMRs) across four time-periods and quantified the absolute and proportional contribution of specific causes to excess mortality using excess mortality rates per 100,000 person-years and attributable fractions. Findings: The analytic cohort comprised 255,448 individuals contributing 2,204,719 person-years. The life expectancy gap narrowed significantly for both sexes (p < 0·001): from 13·4 to 9·4 years in females and 16·7 to 12·1 years in males. All-cause SMRs declined from 2·35 (95% CI 2·23-2·47) to 1·73 (1·67-1·79) in females and 3·12 (2·98-3·25) to 2·10 (2·04-2·16) in males. The gap did not narrow significantly in either sex among people with schizophrenia or other psychoses, in females with affective psychoses, or in females with neurotic or alcohol and substance use disorders. Although intentional self-harm was the largest single contributor to proportional excess mortality in males, the combined excess mortality rate from physical health causes was substantially greater than from self-harm (440·0 and 441·9 versus 163·7 and 83·5 per 100,000 person-years in males and females respectively). Interpretation: The life expectancy gap between people with psychiatric disorders and the general population in Queensland has narrowed over 14 years, although the absolute gap remains considerable, and people with schizophrenia and related psychotic disorders have not shared equally in these gains. Physical illness is the principal driver of excess mortality, therefore prioritising physical health care for people with mental illness is essential to closing the gap, especially in psychotic disorders. Funding: None.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.